
About
Tom Woiwode has an unusual dual-track career at Versant, having served as startup CBO and COO in operating roles at companies like Amira, Synosia, Flexion, and Okairos before becoming a managing director who has led multiple IPOs and M&A exits including CRISPR Therapeutics, Audentes, Gritstone, and Vividion. As a PhD medicinal chemist who started in drug discovery at XenoPort, he brings direct scientific experience from the bench that he applies to company-building and investing, and he frequently partners early with prominent academic scientists to found companies around their work, such as co-founding iECURE with gene therapy pioneer Jim Wilson.
Works at
Investment focus
Investment details
FAQs about Tom Woiwode
Who is Tom Woiwode?
Tom Woiwode has an unusual dual-track career at Versant, having served as startup CBO and COO in operating roles at companies like Amira, Synosia, Flexion, and Okairos before becoming a managing director who has led multiple IPOs and M&A exits including CRISPR Therapeutics, Audentes, Gritstone, and Vividion.
What does Tom Woiwode invest in?
Tom Woiwode invests in BioTech, Health, MedTech at Series A stages.
Does Tom Woiwode work at Versant Ventures?
Yes. Tom Woiwode is Managing Director at Versant Ventures. See the firm profile and investment details on this page.
Where is Tom Woiwode's IncubatorList profile?
Tom Woiwode's investor profile is at incubatorlist.com/tom-woiwode. It lists stages, sectors, check size, and firm affiliation.